BFM
DNA icon

Boothbay Fund Management’s Ginkgo Bioworks DNA Stock Holding History

Boothbay Fund Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-222,200
Closed -$2.18M – 1493
2024
Q4 		$2.18M Buy
+222,200
New +$1.9M 0.05% 428
2022
Q2 		– Sell
-1,345
Closed -$217K – 2342
2022
Q1 		$217K Buy
+1,345
New +$262K 0.01% 1835

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Boothbay Fund Management's DNA Position: Q2 2025 in Review

Boothbay Fund Management sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 20,534 shares — an estimated $117K sold.

Boothbay Fund Management first reported a position in DNA in Q4 2021 and held it in 12 quarters. The position peaked at $969K in Q1 2022. 165 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

  • Boothbay Fund Management reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 20,534 Ginkgo Bioworks shares in Q2 2025, an estimated $117K.
  • Boothbay Fund Management first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 12 quarters.
  • Boothbay Fund Management's Ginkgo Bioworks position peaked at $969K in Q1 2022.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Boothbay Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.